Sangamo Therapeutics (SGMO) Insider Trading & Ownership → The 2024 Gold Rush: Unleashing Market Potential (From Priority Gold) (Ad) Free SGMO Stock Alerts $0.61 0.00 (-0.55%) (As of 12:09 PM ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Sangamo Therapeutics (NASDAQ:SGMO) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage2.80%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)1Amount OfInsider Selling(Last 12 Months)$3 M Get SGMO Insider Trade Alerts Want to know when executives and insiders are buying or selling Sangamo Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address SGMO Insider Buying and Selling by Quarter Ad Priority GoldThe 2024 Gold Rush: Unleashing Market PotentialWelcome to the financial rollercoaster of 2024, where inflation is persistent, stock markets are overinflated and volatile, global conflicts are intensifying, and the national debt is reaching new heights.Get your free information kit NOW, before it's too late. Sangamo Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails9/26/2023Biogen Inc.Major ShareholderSell6,000,000$0.50$3,000,000.00 (Data available from 1/1/2013 forward) SGMO Insider Trading Activity - Frequently Asked Questions Who is on Sangamo Therapeutics's Insider Roster? The list of insiders at Sangamo Therapeutics includes Biogen Inc., and John Markels. Learn more on insiders at SGMO. What percentage of Sangamo Therapeutics stock is owned by insiders? 2.80% of Sangamo Therapeutics stock is owned by insiders. Learn more on SGMO's insider holdings. Which Sangamo Therapeutics insiders have been buying company stock? The following insider purchased SGMO shares in the last 24 months: John Markels ($25,032.96). How much insider buying is happening at Sangamo Therapeutics? Insiders have purchased a total of 6,784 SGMO shares in the last 24 months for a total of $25,032.96 bought. Which Sangamo Therapeutics insiders have been selling company stock? The following insider sold SGMO shares in the last 24 months: Biogen Inc. ($5,132,000.00). How much insider selling is happening at Sangamo Therapeutics? Insiders have sold a total of 6,400,000 Sangamo Therapeutics shares in the last 24 months for a total of $5,132,000.00 sold. More Insider Trading Tools from MarketBeat Related Companies: CRIS Insider Trades SABS Insider Trades AGEN Insider Trades BLUE Insider Trades DBVT Insider Trades BCAB Insider Trades LIFE Insider Trades OMGA Insider Trades SCLX Insider Trades VIGL Insider Trades Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: Insider Trading is Good News for These Stocks4 Small-Cap Energy Stocks Insiders are Buying 3 Penny Stocks That Insiders Are BuyingThe 3 Hottest Insiders Buys This Month 3 Companies Buying Back Cheap Stock Lately This page (NASDAQ:SGMO) was last updated on 5/21/2024 by MarketBeat.com Staff From Our PartnersExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersBill Gates is all about this tiny $2 stockTimothy SykesConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsDoes this make you sick?Allegiance Gold[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 MediaThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldHe Is Giving Away BitcoinCrypto Swap ProfitsNext President (Not Trump. Not Biden.)The Freeport Society Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sangamo Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.